Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Stock Ideas
ETF Research Tools
ETF Center
ETF Screener
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Portfolio
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More...
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Stock Ideas
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETFs
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Dividends
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto
Crypto Center
Bitcoin
Ethereum
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Portfolio
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
News
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
More
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
MTEM
Stock Latest News
Press Releases
Molecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma
20h ago
MTEM
Press Releases
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
6d ago
MTEM
Press Releases
Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update
17d ago
MTEM
The Fly
Molecular Templates announces partial clinical hold for Phase 1 study of MT-0169
2M ago
MTEM
Press Releases
Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169
2M ago
MTEM
Press Releases
Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update
2M ago
MTEM
The Fly
Molecular Templates reports Q4 EPS 39c, consensus (30c)
2M ago
MTEM
Pre-Earnings
Molecular Templates (MTEM) Q4 Earnings Cheat Sheet
2M ago
MTEM
Press Releases
Molecular Templates Announces IND Acceptance by FDA for MT-8421 ETB Program Targeting CTLA-4
3M ago
MTEM
The Fly
Molecular Templates announces FDA accepts IND for MT-8421 ETB program
3M ago
MTEM
Press Releases
Molecular Templates Announces Participation in Upcoming Conferences
3M ago
MTEM
Press Releases
Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting
6M ago
MTEM
Press Releases
Molecular Templates, Inc. to Present Fireside Chats at Two Upcoming Investor Conferences: Evercore ISI’s 5th Annual HealthCONx Conference and Piper Sandler’s 34th Annual Healthcare Conference
6M ago
MTEM
The Fly
Molecular Templates reports Q3 EPS (44c), consensus (48c)
7M ago
MTEM
Press Releases
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
7M ago
MTEM
Press Releases
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
7M ago
MTEM
Press Releases
Molecular Templates, Inc. to Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
7M ago
MTEM
Press Releases
Molecular Templates Announces Participation in Four Upcoming Conferences
9M ago
MTEM
Press Releases
Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results
10M ago
MTEM
Stock Analysis & Ideas
2 “Strong Buy” Stocks Trading at Steep Discounts
2y ago
INZY
MTEM
Market News
Insider Buying Of Molecular Templates Stock Corresponds With Analyst Ratings
2y ago
MTEM
Stock Analysis & Ideas
Oppenheimer Sees These 3 Stocks Skyrocketing Over 100%
3y ago
MTEM
SBBP
You need to enable JavaScript to run this app.